April 2024 Brief
April has been a monumental month for cannabis worldwide, with the DEA endorsing rescheduling and a surge in enrolment in Germany after legalisation. Other interesting news from last month include: Australian regulator pledges to increase testing on imported products. Argentina wants to tighten patient registry conditions. Permits for over 2,500ha already awarded this year in […]
March 2024 Brief
Cannabis is now legal in Germany! Biden and Trudeau endorse timid cannabis reform in the US and Canada, while the Israeli protectionist trend reaches Australia. Demand accelerates in Australia, Germany and Poland. New wave of market consolidation and M&A in Israel, Canada and the UK. Morocco has completed its first legal harvest, new products are registered in Portugal, and Swiss recreational pilot projects with 15,000 users anounce initial results. Reviews address contaminant control in greenhouse […]
February 2024 Brief
Hi , welcome to your cannabis brief! We discuss German legalisation, US rescheduling debates, excise tax reforms in Canada and medicinal cannabis regulations in Spain. German distributors broaden product portfolios ahead of legalisation, Israeli market is seeing an uptick despite consolidation, new market entries in Poland and the first legal sales in Greece. Studies on cannabis use and anxiety point to a positive impact, despite the fact that people suffering […]
January 2024 Brief
Hi , welcome to this packed cannabis brief! We discuss the global reckoning with the failures of prohibition, including cannabis rescheduling in the US, decriminalisation in the Czech Republic, and industry petitions to tweak regulations in Israel, Germany, Canada, the UK and Uruguay. Australia has been the focus of new international trade agreements in the first month of 2024, as sector grows […]
December 2023 Brief
Hi , welcome to your first cannabis brief of 2024. We discuss the launch of the recreational experiment in the Netherlands, cannabis rescheduling in the US, medical legalisation in Ukraine and Spain, as well as regulatory changes in Canada, France, Israel and Germany. December has been a slow month on the commercial front. However, both industry and regulators have published interesting data on the Australian, German, Israeli and […]
November 2023 Brief
Dear reader, welcome to your monthly cannabis brief. We discuss the Netherlands getting ready to launch the supply chain experiment in December, German legalisation delays and draft changes, Japan and Canada approving pharmaceutical cannabis products, and US rescheduling debates. Australian, UK and Brazilian medical markets remain highly dynamic with new entries, Germany, Portugal, Israel and […]
October 2023 Brief
We discuss effects of the war in the Israeli market, UK CBD regulatory changes, the future of the French medical scheme, and the legislative process in Germany. Canada celebrates 5 years of legalisation amidst sector consolidation, while momentum in the Australian and UK medical markets perseveres, and the Dutch recreational experiment readies for launch later this year. Studies on the ‘entourage effect‘ support greater effects of full-spectrum cannabis […]
September 2023 Brief
European rec legalisation, surge of private clinics and international markets teeming with activity. A continental-wide policy shift is underway spearheaded by German legalisation, as well as commercial supply chain models like that of the Netherlands. September has also seen an uptick of deals in the German and Australian medical markets, particularly in the telehealth and private clinic segments. New export milestones by Canada, Uruguay, Portugal and New Zealand reflect on […]
August 2023 Brief
Revamping of regulations, mixed news for the CBD sector and launches of new medical cannabis products. August has seen a revamping of cannabis regulations in Israel and Argentina, and positive signs for the federal status of cannabis in the US and Germany. Israel will legalise over-the-counter CBD, while Italy, Portugal and Brazil tighten up rules for CBD market […]
July 2023 Brief
Market consolidation perseveres, regulatory roll-out intensifies. July has been a particularly productive month in the regulatory front with Germany, Ukraine, Brazil, Albania, New Zealand and Ghana announcing legal changes. The cannabis market is in the midst of a major consolidation: M&A, cost-cutting initiatives and facility closures have become a normal occurrence in 2023, and July has seen an […]